MDMA Statement on House MDUFA Hearing
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the House Energy and Commerce Subcommittee on Health hearing entitled “Reauthorization of MDUFA: What it Means for Jobs, Innovation and Patients:”
“MDMA appreciates all of the House Subcommittee's work on the important issue of medical device innovation.
“The user fee reauthorization for medical devices is a critical component to ensure that the United States doesn't lose our leadership position in driving patient care and job creation.
“MDMA continues working with FDA, Congress and stakeholders on our common goals to restore predictability and transparency with the premarket review process, and to help America’s medical device innovators continue delivering novel advancements in patient care."